2022-02-01 FIMECS Announces Strategic Research Collaboration with Astellas to Discover Protein Degraders Against Multiple Targets
2022-01-24 FIMECS Announces 1,175 Million JPY (ca. 10.3 Million USD) Series B Financing to Advance its Protein Degrader Pipeline and Platform
2021-01-21 FIMECS is Named by The 2020 APAC Business Awards as Best Tech-Based Drug Discovery Biotech – Japan”
2020-11-12 Publication about the AID2 technology as a collaboration with National Institute of Genetics